Thomas Nelson
14Patents
8h-index
23Co-inventors
64Inventor score
Filing activity: Nov 14, 2001 → Sep 10, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7153678B2 | Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7115402B2 | Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42 | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6642041B2 | Polynucleotides encoding a novel metalloprotease, MP-1 | Chemistry; Metallurgy | 11 | Expired |
| US7186564B2 | Polynucleotides encoding novel cysteine proteases of the calpain superfamily, CAN-12v1 and CAN-12v2. | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7247717B2 | Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 | Chemistry; Metallurgy | 9 | Expired |
| US7256267B2 | Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 | Chemistry; Metallurgy | 9 | Expired |
| US7273706B2 | Method of diagnosing testicular tumors using polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42 | Emerging Cross-Sectional Technologies | 9 | Active |
| US7122358B2 | Testis-specific tubulin tyrosine-ligase-like protein, BGS42 | Chemistry; Metallurgy | 9 | Expired |
| US7312086B2 | Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23 | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7713699B2 | Methods of diagnosing colon adenocarcinoma using mRNA encoding the human g-protein coupled receptor, HGPRBMY23 | Emerging Cross-Sectional Technologies | 1 | Active |
| US7259002B2 | Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof | Human Necessities | 0 | Expired |
| US7811787B2 | Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3 | Physics | 0 | Active |
| US7309779B2 | Antibodies directed to the testis-specific tubulin tyrosine-ligase-like protein, BGS42 | Emerging Cross-Sectional Technologies | 0 | Active |
| US7741025B2 | Method of diagnosing lung cancer using BGS42 | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.